NVSEF NOVARTIS AG-REG
FollowFOREIGN (common), issuer CIK 1114448
4 managers (4 13F filers) reported a position in NVSEF shares at 2025-09-30, 190,087 shares in all. 1 filer opened a position and 1 filer sold out during the quarter.
- Managers
- 4
- 13F filers
- 4
- New
- 1
- Added
- 0
- Reduced
- 2
- Sold out
- 1
- Shares held by filers
- 190,087
Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.
13D and 13G filers
No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.
Insider trades
No Form 4 transaction on this security in the data.
13F holders, Q3 2025
Filers in the available 13F reports with a share position at 2025-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| Boston Common Asset Management, LLC | 129,013 | $16.2M | 0.45% | -24,819 | 13F-HRTimeline |
| PARTNERS CAPITAL INVESTMENT GROUP, LLP | 42,461 | $5.34M | 0.21% | 0 | 13F-HRTimeline |
| Generali Investments CEE, investicni sp… | 18,053 | $2.27M | 0.17% | -1,222 | 13F-HRTimeline |
| Saranac Partners Ltd | 560 | $70.5K | 0.01% | new | 13F-HRTimeline |